Mark C. Schiller's most recent trade in Kezar Life Sciences Inc was a trade of 561 Common Stock done at an average price of $4.3 . Disclosure was reported to the exchange on July 2, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Kezar Life Sciences Inc | Mark Schiller C. | Chief Operating Officer | Sale of securities on an exchange or to another person at price $ 4.28 per share. | 02 Jul 2025 | 561 | 2,739 (0%) | 0% | 4.3 | 2,401 | Common Stock |
| Kezar Life Sciences Inc | Mark C. Schiller | Chief Legal Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 Mar 2025 | 4,800 | 12,000 | - | - | Employee Stock Option (right to buy) | |
| Kezar Life Sciences Inc | Mark C. Schiller | Chief Legal Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Mar 2025 | 7,200 | 7,200 | - | - | Employee Stock Option (right to buy) | |
| Kezar Life Sciences Inc | Mark C. Schiller | Chief Legal Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Jan 2025 | 24,500 | 24,500 | - | - | Employee Stock Option (right to buy) | |
| Kezar Life Sciences Inc | Mark C. Schiller | Chief Legal Officer | Sale of securities on an exchange or to another person at price $ 0.58 per share. | 02 Jul 2024 | 6,688 | 33,007 (0%) | 0% | 0.6 | 3,879 | Common Stock |